Literature DB >> 30649582

[Instillation therapies for urothelial carcinoma of the upper urinary tract].

P Bosshard1, G N Thalmann2, B Roth1.   

Abstract

Traditionally, urothelial carcinoma of the upper urinary tract was a clear indication for radical nephroureterectomy with bladder cuff excision. It has been shown that in well-selected patients and depending on tumor stage, a kidney-sparing approach can be pursued with good oncological outcome and equivalent to the radical approach. The prevention of local and bladder recurrences is an important factor. Instillation therapies with bacillus Calmette-Guérin and/or mitomycin C have been successfully used to this end. Due to the low incidence of upper tract urothelial cancer and due to the usually retrospective nature of existing literature, however, data is limited. In this article, we provide a review of the indication, technical execution and results of instillation therapies of the upper urinary tract.

Entities:  

Keywords:  Bacillus Calmette-Guérin; Carcinoma in situ; Mitomycin C; Nephroureterectomy; Vesico-ureteral reflux

Mesh:

Year:  2019        PMID: 30649582     DOI: 10.1007/s00120-018-0830-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  30 in total

1.  Genomic Characterization of Upper Tract Urothelial Carcinoma.

Authors:  John P Sfakianos; Eugene K Cha; Gopa Iyer; Sasinya N Scott; Emily C Zabor; Ronak H Shah; Qinghu Ren; Aditya Bagrodia; Philip H Kim; A Ari Hakimi; Irina Ostrovnaya; Ricardo Ramirez; Aphrothiti J Hanrahan; Neil B Desai; Arony Sun; Patrizia Pinciroli; Jonathan E Rosenberg; Guido Dalbagni; Nikolaus Schultz; Dean F Bajorin; Victor E Reuter; Michael F Berger; Bernard H Bochner; Hikmat A Al-Ahmadie; David B Solit; Jonathan A Coleman
Journal:  Eur Urol       Date:  2015-08-14       Impact factor: 20.096

2.  Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

Authors:  William C Huang; Andrew S Levey; Angel M Serio; Mark Snyder; Andrew J Vickers; Ganesh V Raj; Peter T Scardino; Paul Russo
Journal:  Lancet Oncol       Date:  2006-09       Impact factor: 41.316

3.  Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma.

Authors:  Adam J Gadzinski; William W Roberts; Gary J Faerber; J Stuart Wolf
Journal:  J Urol       Date:  2010-06       Impact factor: 7.450

4.  Ureteropyeloscopic diagnosis and treatment of upper urinary tract urothelial malignancies.

Authors:  M Grasso; M Fraiman; M Levine
Journal:  Urology       Date:  1999-08       Impact factor: 2.649

5.  Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.

Authors:  Morgan Rouprêt; Vincent Hupertan; Olivier Traxer; Guillaume Loison; Emmanuel Chartier-Kastler; Pierre Conort; Marc-Olivier Bitker; Bernard Gattegno; François Richard; Olivier Cussenot
Journal:  Urology       Date:  2006-06       Impact factor: 2.649

6.  Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.

Authors:  Evanguelos Xylinas; Michael Rink; Vitaly Margulis; Thomas Clozel; Richard K Lee; Evi Comploj; Giacomo Novara; Jay D Raman; Yair Lotan; Alon Weizer; Morgan Roupret; Armin Pycha; Douglas S Scherr; Christian Seitz; Vincenzo Ficarra; Quoc-Dien Trinh; Pierre I Karakiewicz; Francesco Montorsi; Marc Zerbib; Shahrokh F Shariat
Journal:  BJU Int       Date:  2013-03-06       Impact factor: 5.588

7.  Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.

Authors:  Mark L Cutress; Grant D Stewart; Simon Wells-Cole; Simon Phipps; Ben G Thomas; David A Tolley
Journal:  BJU Int       Date:  2012-05-07       Impact factor: 5.588

8.  Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.

Authors:  R Houston Thompson; Amy E Krambeck; Christine M Lohse; Daniel S Elliott; David E Patterson; Michael L Blute
Journal:  Urology       Date:  2008-02-11       Impact factor: 2.649

9.  Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience.

Authors:  T W Jarrett; P M Sweetser; G H Weiss; A D Smith
Journal:  J Urol       Date:  1995-11       Impact factor: 7.450

10.  Mitomycin C instillation following ureterorenoscopic laser ablation of upper urinary tract carcinoma.

Authors:  Omar M Aboumarzouk; Bhaskar Somani; Sarfraz Ahmad; Ghulam Nabi; Nicholas Townell; Slawomir G Kata
Journal:  Urol Ann       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.